February 05, 2007

A pilot study to obtain initial information on gene expression in the human intervetebral disc: The original and fate of the nucleus pulposus.

IRB Number: 26114

Institutional Review Board
Hospital for Special Surgery

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Federico Girardi, MD

Co-Investigators

Frank Cammisa, MD
Andrew Sama, MD
Stephen Doty, MD
Joseph Schwab, MD
John H. Healey, MD

Contact Information

Kai Zhang
Spine Service Research Coordinator
212.774.7066
Zhangk@hss.edu